1 – 12 of 12
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Heterogeneity of Colorectal Cancer Risk Factors by Anatomical Subsite in 10 European Countries: A Multinational Cohort Study
(
- Contribution to journal › Article
- 2018
-
Mark
Expression of programmed cell death protein 1 (PD-1) and its ligand PD-L1 in colorectal cancer : Relationship with sidedness and prognosis
(
- Contribution to journal › Article
- 2017
-
Mark
Associations of defect mismatch repair genes with prognosis and heredity in sporadic colorectal cancer
(
- Contribution to journal › Article
-
Mark
Multi-parametric profiling of renal cell, colorectal, and ovarian cancer identifies tumour-type-specific stroma phenotypes and a novel vascular biomarker
(
- Contribution to journal › Article
-
Mark
Genetic variation in the ADIPOQ gene, adiponectin concentrations and risk of colorectal cancer : a Mendelian Randomization analysis using data from three large cohort studies
(
- Contribution to journal › Article
-
Mark
Association of the oestrogen receptor beta with hormone status and prognosis in a cohort of female patients with colorectal cancer
(
- Contribution to journal › Article
-
Mark
The clinical impact of tumour-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite : A cohort study
(
- Contribution to journal › Article
- 2016
-
Mark
Significant association and synergistic adverse prognostic effect of podocalyxin-like protein and epidermal growth factor receptor expression in colorectal cancer
(
- Contribution to journal › Article
- 2014
-
Mark
Coffee and tea consumption, genotype- based CYP1A2 and NAT2 activity and colorectal cancer risk- Results from the EPIC cohort study
(
- Contribution to journal › Article
- 2013
-
Mark
Sex differences in the prognostic significance of KRAS codons 12 and 13, and BRAF mutations in colorectal cancer: a cohort study
(
- Contribution to journal › Article
- 2011
-
Mark
High nuclear RBM3 expression is associated with an improved prognosis in colorectal cancer
(
- Contribution to journal › Article
-
Mark
Growth differentiation factor 15: a prognostic marker for recurrence in colorectal cancer
(
- Contribution to journal › Article